Mar 15, 2023
Addition of Two New Board Members Represents Inflection Point for Neosoma, Inc.
We're very excited to announce that Debbie Millin and Fred Driscoll have joined our Board of Directors. This appointment and expansion comes at an important time for Neosoma, as we accelerate our commercial traction, grow our team, and expand our product portfolio.
“Key to executing on our strategy is ensuring that the company has a diverse and experienced board of directors,” said Ken Kolodziej, Neosoma’s CEO and Co-Founder. “Debbie and Fred each bring a wealth of operational and strategic expertise to scaling software and life sciences businesses, as well as a passion for our mission. Together, their involvement sets Neosoma up well for our next phase of growth; I couldn’t be more excited.”
Debbie and Fred will play crucial roles in applying their expertise and strategic guidance in the months and years to come, in supporting Neosoma's mission to become the industry leader in the neuro- and CNS oncology software space, helping physicians maximize their positive impact on patient treatment and outcomes.
Read the full press release here.